{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T16:23:36Z","timestamp":1774715016271,"version":"3.50.1"},"reference-count":25,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.jaad.2016.02.1218","type":"journal-article","created":{"date-parts":[[2016,3,24]],"date-time":"2016-03-24T10:00:54Z","timestamp":1458813654000},"page":"59-63.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["Propranolol treatment of infantile hemangioma (IH) is not associated with developmental risk or growth impairment at age 4\u00a0years"],"prefix":"10.1016","volume":"75","author":[{"given":"Andre Vadimovich","family":"Moyakine","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorien Maria","family":"Kerstjens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saskia","family":"Spillekom-van Koulil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catharina Joanna Maria","family":"van der Vleuten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2016.02.1218_bib1","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1056\/NEJMoa1404710","article-title":"A randomized, controlled trial of oral propranolol in infantile hemangioma","volume":"372","author":"Leaute-Labreze","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2016.02.1218_bib2","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1542\/peds.2012-1691","article-title":"Initiation and use of propranolol for infantile hemangioma: report of a consensus conference","volume":"131","author":"Drolet","year":"2013","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaad.2016.02.1218_bib3","doi-asserted-by":"crossref","first-page":"e259","DOI":"10.1542\/peds.2010-0029","article-title":"A randomized controlled trial of propranolol for infantile hemangiomas","volume":"128","author":"Hogeling","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaad.2016.02.1218_bib4","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1016\/j.jpedsurg.2013.08.020","article-title":"Effect of propranolol vs prednisolone vs propranolol with prednisolone in the management of infantile hemangioma: a randomized controlled study","volume":"48","author":"Malik","year":"2013","journal-title":"J Pediatr Surg"},{"key":"10.1016\/j.jaad.2016.02.1218_bib5","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1684\/ejd.2013.2146","article-title":"Propranolol and infantile\u00a0hemangiomas: different routes of administration, a randomized clinical trial","volume":"23","author":"Zaher","year":"2013","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.jaad.2016.02.1218_bib6","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1056\/NEJMc0708819","article-title":"Propranolol for severe hemangiomas of infancy","volume":"358","author":"Leaute-Labreze","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2016.02.1218_bib7","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1111\/bjd.12189","article-title":"Propranolol in a case series of 174 patients with complicated infantile hemangioma: indications, safety and future directions","volume":"168","author":"Hermans","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2016.02.1218_bib8","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.4172\/2329-9495.1000e101","article-title":"Reconsidering the use of propranolol in the treatment of cosmetic infantile hemangiomas","volume":"1","author":"Bryan","year":"2013","journal-title":"Angiol"},{"key":"10.1016\/j.jaad.2016.02.1218_bib9","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/bjd.13379","article-title":"Propranolol and central nervous system function: potential implications for pediatric patients\u00a0with infantile hemangiomas","volume":"172","author":"Langley","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2016.02.1218_bib10","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.pcl.2011.03.002","article-title":"Cognitive, behavioral, and functional consequences of inadequate sleep in children and adolescents","volume":"58","author":"Beebe","year":"2011","journal-title":"Pediatr Clin North Am"},{"key":"10.1016\/j.jaad.2016.02.1218_bib11","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1365-2869.2011.00962.x","article-title":"Acute sleep restriction effects on emotion responses in 30- to 36-month-old children","volume":"21","author":"Berger","year":"2012","journal-title":"J Sleep Res"},{"key":"10.1016\/j.jaad.2016.02.1218_bib12","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1080\/87565641.2013.799169","article-title":"A one-hour sleep restriction impacts brain processing in young children across tasks: evidence from event-related potentials","volume":"38","author":"Molfese","year":"2013","journal-title":"Dev Neuropsychol"},{"key":"10.1016\/j.jaad.2016.02.1218_bib13","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/1467-8624.00414","article-title":"Sleep, neurobehavioral functioning, and behavior problems in school-age children","volume":"73","author":"Sadeh","year":"2002","journal-title":"Child Dev"},{"key":"10.1016\/j.jaad.2016.02.1218_bib14","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.jaad.2015.04.053","article-title":"Propranolol treatment of infantile hemangiomas does not negatively affect psychomotor development","volume":"73","author":"Moyakine","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2016.02.1218_bib15","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/bdrb.20238","article-title":"Antihypertensive medication\u00a0use during pregnancy and the risk of major\u00a0congenital malformations or small-for-gestational-age newborns","volume":"89","author":"Nakhai-Pour","year":"2010","journal-title":"Birth Defects Res B Dev Reprod Toxicol"},{"key":"10.1016\/j.jaad.2016.02.1218_bib16","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0895-7061(99)00031-X","article-title":"Atenolol and fetal growth in pregnancies complicated by hypertension","volume":"12","author":"Lydakis","year":"1999","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.jaad.2016.02.1218_bib17","doi-asserted-by":"crossref","first-page":"e001185","DOI":"10.1136\/bmjopen-2012-001185","article-title":"\u03b2-Blocker treatment during pregnancy and adverse pregnancy outcomes: a nationwide population-based cohort study","volume":"2","author":"Meidahl Petersen","year":"2012","journal-title":"BMJ Open"},{"key":"10.1016\/j.jaad.2016.02.1218_bib18","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/1471-0528.12522","article-title":"Treatment with oral beta-blockers during pregnancy complicated by maternal heart disease increases\u00a0the risk of fetal growth restriction","volume":"121","author":"Ersboll","year":"2014","journal-title":"BJOG"},{"key":"10.1016\/j.jaad.2016.02.1218_bib19","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.earlhumdev.2013.08.016","article-title":"Validity and internal consistency of the Ages and Stages Questionnaire 60-month version and the effect of three scoring methods","volume":"89","author":"Hornman","year":"2013","journal-title":"Early Hum Dev"},{"key":"10.1016\/j.jaad.2016.02.1218_bib20","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.earlhumdev.2009.03.001","article-title":"Support for the global feasibility of the Ages and Stages Questionnaire as developmental screener","volume":"85","author":"Kerstjens","year":"2009","journal-title":"Early Hum Dev"},{"key":"10.1016\/j.jaad.2016.02.1218_bib21","doi-asserted-by":"crossref","first-page":"e1187","DOI":"10.1542\/peds.2010-3781","article-title":"Growth and predictors of growth restraint in moderately preterm children aged 0 to 4 years","volume":"128","author":"Bocca-Tjeertes","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaad.2016.02.1218_bib22","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/ajd.12156","article-title":"Retrospective follow up of gross motor development in children using propranolol for treatment of infantile hemangioma at Sydney Children's Hospital","volume":"53","author":"Gonski","year":"2014","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.jaad.2016.02.1218_bib23","first-page":"733","article-title":"Age at stroke determines post-stroke language lateralization","volume":"32","author":"Szaflarski","year":"2014","journal-title":"Restor Neurol Neurosci"},{"key":"10.1016\/j.jaad.2016.02.1218_bib24","unstructured":"Giese R CM, Boswell J, Suen J, Richter G. Efficacy and effect on growth and development. Presented at the 20th International Society for the Study of Vascular Anomalies Congress in Melbourne."},{"key":"10.1016\/j.jaad.2016.02.1218_bib25","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s00228-009-0620-0","article-title":"Maternal use of antihypertensive drugs in early pregnancy and delivery outcome, notably the presence of congenital heart defects in the infants","volume":"65","author":"Lennestal","year":"2009","journal-title":"Eur J Clin Pharmacol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962216014833?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962216014833?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:39:56Z","timestamp":1759271996000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962216014833"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S0190962216014833"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2016.02.1218","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Propranolol treatment of infantile hemangioma (IH) is not associated with developmental risk or growth impairment at age 4\u00a0years","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2016.02.1218","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}